Wallstreetbets

Lightly traded, small float penny stocks have been on major runs this week. On Monday, FNHC was the big winner, running to as high as $0.69 from $0.12 the previous day. BTB and CNXA were the big winners on Tuesday, both running well in excess of 100%. On Wednesday, CRKN was the big winner, more than doubling at its high. Finally, today STAB was the one that doubled. FNGR has been on a multi-day run, leading to a 10-bagger for those who bought near the bottom. There is a commonality to all of these stocks. Other than their spike days, they are lightly traded, usually less than one million volume in a day, and had a major gap to fill.  One stock that makes an excellent candidate to be the next major penny stock spiker is PHAS. Particularly since STAB made a run today, so the trading opportunities are starting to head towards biotech. We saw a glimpse of what can happen as it shot up 10% in the last five minutes of trading today. PHAS has a major gap to fill from last week between $0.40 a

Lightly traded, small float penny stocks have been on major runs recently. BTB and CNXA were up well over 100% during Tuesday's trading while FNHC went on a major run on Monday before it pulled back. FNGR has been on a major run of 1,000%. There is a commonality to all of these stocks. Other than their spike days, they are lightly traded, usually less than one million volume in a day, and had a major gap to fill.  One stock that makes an excellent candidate to be the next major penny stock spiker is PHAS. It has a major gap to fill from last week between $0.40 and $0.75: It tanked on bad news that its partner is trying to take the lead drug candidate for themselves, citing PHAS' weak financial state as the reason. Reading the 8-K filing , PHAS still has some legal premise to defend against its partner from taking the lead drug candidate for themselves so there's still hope/hype of recovery. The stock has cratered on light volume, with 6.6 million shares traded on the day af